首页 / 院系成果 / 成果详情页

S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension  期刊论文  

  • 编号:
    a4e54f8b-2cdf-42b2-9ee6-241986d37361
  • 作者:
  • 语种:
    英文
  • 期刊:
    BIOMEDICINE & PHARMACOTHERAPY ISSN:0753-3322 2019 年 114 卷 ; JUN
  • 收录:
  • 关键词:
  • 摘要:

    S-amlodipine has been broadly used to treat hypertension, but its protective effects and underlying mechanism remain controversial. The purpose of our study was to investigate the mechanism by which S-amlodipine improves endothelial dysfunction. Specifically, we investigated if S-amlodipine regulates RANK/RANKL/OPG and micro-RNA 155 (miR-155) levels. Spontaneous hypertensive rats (SHR) were randomly divided into two groups: SHR (n = 12) and S-amlodipine (n = 12). We found that left ventricular ejection fraction (LVEF) increased significantly in the S-amlodipine group compared to the SHR group. After 10 weeks of S-amlodipine treatment, tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) levels were significantly lower and eNOS and NO production was significantly higher in the S-amlodipine group compared to the SHR group. In human umbilical vein endothelial cells (HUVECs), miR-155, RANK, and RANKL levels were significantly decreased, while OPG mRNA levels were significantly increased in the S-amlodipine group. HUVECs were transfected with miR-155 mimics or an inhibitor to determine the relationship between miR-155 and RANK/RANKL/OPG and NF-kappa B signaling. OPG mRNA levels following miR-155 inhibition were significantly higher compared to levels following treatment with miR-155 mimics. S-amlodipine significantly inhibited RANKL expression and NF-kappa B phosphorylation, and there were no significant differences in response to the NF-kappa B inhibitor (Bay110785). RANKL expression and NF-kappa B phosphorylation significantly decreased in the miR-155 inhibitor group. Furthermore, OPG protein expression significantly increased in response to miR-155 inhibition and S-amlodipine treatment (all p < 0.05). Our results indicate that S-amlodipine inhibits inflammation and protects against endothelial dysfunction, likely via regulating the RANK/RANKL/OPG pathway, which appears to be downstream of miR-155.

  • 推荐引用方式
    GB/T 7714:
    Yang Jining,Si Daoyuan,Zhao Yanan, et al. S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension [J].BIOMEDICINE & PHARMACOTHERAPY,2019,114.
  • APA:
    Yang Jining,Si Daoyuan,Zhao Yanan,He Chengyan,&Yang Ping.(2019).S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension .BIOMEDICINE & PHARMACOTHERAPY,114.
  • MLA:
    Yang Jining, et al. "S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension" .BIOMEDICINE & PHARMACOTHERAPY 114(2019).
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:103 下载次数:0
浏览次数:103
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部